Biosimilar Cancer Drug Threat Closing in for Roche Biosimilar Cancer Drug Threat Closing in for Roche

The long-heralded threat of cut-price competition to its top-selling biological cancer medicines is finally becoming a reality for Roche, the world ' s biggest maker of oncology treatments.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news